Light Degradable Drug Delivery System For Effective Ocular Therapy
University researchers have developed compositions and methods that enable light-triggered ocular drug delivery utilizing a polymer that degrades upon exposure to specific wavelength(s) of light.
Inventor: ALMUTAIRI, Adah | ALMUTAIRI, Khalid
Priority Number: WO2013169955A1
IPC Current: A61N000500 | A61B001804 | B82Y000500
Assignee Applicant: The Regents of the University of California
Title: FINE SPATIOTEMPORAL CONTROL OF THERMOLYSIS AND LIPOLYSIS USING NIR LIGHT | RÉGLAGE SPATIO-TEMPOREL FIN DE LA THERMOLYSE ET DE LA LIPOYSE AU MOYEN D'UNE LUMIÈRE INFRAROUGE PROCHE
Usefulness: FINE SPATIOTEMPORAL CONTROL OF THERMOLYSIS AND LIPOLYSIS USING NIR LIGHT | RÉGLAGE SPATIO-TEMPOREL FIN DE LA THERMOLYSE ET DE LA LIPOYSE AU MOYEN D'UNE LUMIÈRE INFRAROUGE PROCHE
Summary: System for minimally-invasive lipolysis in a target area to remove fatty tissue using infrared laser light for a patient.
Novelty: System for minimally-invasive lipolysis in target area to remove of fatty tissue using infrared laser light for patient, has emission wavelength adapted to excite biocompatible nanoparticles to melt fat within target area
診斷/治療
其他疾病
State Of Development Proof of concept has been achieved through in vitro and in vivo experiments. Intellectual Property Info The invention has a patent pending and is available for licensing. Related Cases Tech ID/UC Case 23225/2012-355-0 Related Cases 2012-355-0
美國

